Abnormal cervical cytology and health care use: A population-based register study

• We did a nationwide population-based study.
• We assess the use of health care services in women with abnormal cytology.
• These women constitute a selected group with a higher health care use, before.
• We did not observe any additional burden of the abnormal result.

ObjectiveThis study aimed to assess the long-term use of health care services in women with abnormal cytology results compared to women with normal cytology results.MethodsWe did a nationwide population-based study, using women aged 23 to 59 years participating in the national organized cervical cancer screening program. We included a study population of 40,153 women with abnormal cytology (exposed) and 752,627 women with normal cytology (non-exposed). We retrieved data from the Danish Civil Registration System, the Danish Pathology Data Bank, the National Health Service, the National Patient and the National Prescription Register. We calculated the frequencies of contacts to general practitioner (GP), to private psychiatrist and/or psychologist, admissions to hospitals and use of prescription drugs. These frequencies were calculated separately in the 5-year period “before” the cytology result and for the 5-year period “after” the result.ResultsDuring the “before” period exposed women had more contacts to GPs, more contacts to psychologists/psychiatrist, and more hospital admissions than non-exposed women. In both exposed and non-exposed women, health care use increased from the “before” to the “after” period. This increase was significantly higher for exposed than non-exposed women regarding contacts to GP, admissions to hospitals, and drug use.ConclusionWomen with abnormal cytology results constitute a selected group with a higher health care use than other women even before they have the abnormal cytology. This difference is further enhanced after the abnormal cytology result.